Literature DB >> 12397156

Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive parkinsonism.

E Muñoz1, E Tolosa, P Pastor, M J Martí, F Valldeoriola, J Campdelacreu, R Oliva.   

Abstract

BACKGROUND: Autosomal recessive juvenile parkinsonism is a neurodegenerative disorder associated with mutations in the parkin gene.
OBJECTIVES: To search for the presence of parkin gene mutations in Spanish patients with Parkinson's disease (PD) and characterise the phenotype associated with these mutations.
METHODS: Thirty seven PD patients with either early onset or autosomal recessive pattern of inheritance were selected for genetic study.
RESULTS: Mutations were identified in seven index patients (19%). Homozygous mutations were detected in six patients and a heterozygous mutation in one. The age at onset was lower in patients with mutations than in patients without mutations. Dystonia at onset was present in two patients with parkin gene mutations. The disease began in two patients with postural tremor in the upper limbs mimicking essential tremor. Four patients exhibited a long term response to dopamine agonists. The c.255delA mutation was identified in four unrelated families. This is a frameshift mutation leading to protein truncation.
CONCLUSIONS: Parkin gene mutations are present in Spanish patients with early onset and/or an autosomal recessive parkinsonism. The c.255delA is the most frequent mutation found, suggesting a relative high prevalence in the Spanish population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397156      PMCID: PMC1738117          DOI: 10.1136/jnnp.73.5.582

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  Dual Function of Phosphoubiquitin in E3 Activation of Parkin.

Authors:  Erik Walinda; Daichi Morimoto; Kenji Sugase; Masahiro Shirakawa
Journal:  J Biol Chem       Date:  2016-06-09       Impact factor: 5.157

2.  Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Authors:  Karen S Marder; Ming X Tang; Helen Mejia-Santana; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Andrew D Siderowf; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Barbara M Ross; Lucien J Cote; Steven Frucht; Blair Ford; Roy N Alcalay; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Gregory D Neils; Miguel Verbitsky; Sergey Kisselev; Elise Caccappolo; Ruth Ottman; Lorraine N Clark
Journal:  Arch Neurol       Date:  2010-06

Review 3.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

4.  Parkin truncating variants result in a loss-of-function phenotype.

Authors:  Mariana Santos; Sara Morais; Conceição Pereira; Jorge Sequeiros; Isabel Alonso
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

5.  The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.

Authors:  Sara Bandres-Ciga; Sarah Ahmed; Marya S Sabir; Cornelis Blauwendraat; Astrid D Adarmes-Gómez; Inmaculada Bernal-Bernal; Marta Bonilla-Toribio; Dolores Buiza-Rueda; Fátima Carrillo; Mario Carrión-Claro; Pilar Gómez-Garre; Silvia Jesús; Miguel A Labrador-Espinosa; Daniel Macias; Carlota Méndez-Del-Barrio; Teresa Periñán-Tocino; Cristina Tejera-Parrado; Laura Vargas-González; Monica Diez-Fairen; Ignacio Alvarez; Juan Pablo Tartari; Mariateresa Buongiorno; Miquel Aguilar; Ana Gorostidi; Jesús Alberto Bergareche; Elisabet Mondragon; Ana Vinagre-Aragon; Ioana Croitoru; Javier Ruiz-Martínez; Oriol Dols-Icardo; Jaime Kulisevsky; Juan Marín-Lahoz; Javier Pagonabarraga; Berta Pascual-Sedano; Mario Ezquerra; Ana Cámara; Yaroslau Compta; Manel Fernández; Rubén Fernández-Santiago; Esteban Muñoz; Eduard Tolosa; Francesc Valldeoriola; Isabel Gonzalez-Aramburu; Antonio Sanchez Rodriguez; María Sierra; Manuel Menéndez-González; Marta Blazquez; Ciara Garcia; Esther Suarez-San Martin; Pedro García-Ruiz; Juan Carlos Martínez-Castrillo; Lydia Vela-Desojo; Clara Ruz; Francisco Javier Barrero; Francisco Escamilla-Sevilla; Adolfo Mínguez-Castellanos; Debora Cerdan; Cesar Tabernero; Maria Jose Gomez Heredia; Francisco Perez Errazquin; Manolo Romero-Acebal; Cici Feliz; Jose Luis Lopez-Sendon; Marina Mata; Irene Martínez Torres; Jonggeol Jeffrey Kim; Clifton L Dalgard; Janet Brooks; Sara Saez-Atienzar; J Raphael Gibbs; Rafael Jorda; Juan A Botia; Luis Bonet-Ponce; Karen E Morrison; Carl Clarke; Manuela Tan; Huw Morris; Connor Edsall; Dena Hernandez; Javier Simon-Sanchez; Mike A Nalls; Sonja W Scholz; Adriano Jimenez-Escrig; Jacinto Duarte; Francisco Vives; Raquel Duran; Janet Hoenicka; Victoria Alvarez; Jon Infante; Maria José Marti; Jordi Clarimón; Adolfo López de Munain; Pau Pastor; Pablo Mir; Andrew Singleton
Journal:  Mov Disord       Date:  2019-10-29       Impact factor: 10.338

6.  Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD.

Authors:  Sara Morais; Rita Bastos-Ferreira; Jorge Sequeiros; Isabel Alonso
Journal:  Neurol Genet       Date:  2016-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.